VG Life Sciences Competitors and Similar CompaniesClear all
VG Life Sciences's competitors and similar companies include Epizyme and Outlook Therapeutics.
 VG Life Sciences VG Life Sciences (VGLS, also known as SB Technology Holdings, formerly Viral Genetics) is a company that develops therapeutic and diagnostic pharmaceutical and medical products. |  Epizyme Epizyme is a clinical stage biopharmaceutical company focusing on treatments for blood cancer and tumors. |  Outlook Therapeutics Outlook Therapeutics (formerly Oncobiologics) is a clinical stage biopharmaceutical company focused on identifying, developing, manufacturing and commercializing complex biosimilar therapeutics. | |
Founding Date | Founding Date 1995 | Founding Date 2007 | Founding Date 2011 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations New York, US HQ | Locations Cambridge, US HQ | Locations Woodbridge Township, US HQ |
Employees | Employees 1 | Employees 20364% increase | Employees 1726% decrease |
Valuation ($) | Valuation ($) 2.1 m | Valuation ($) 250.8 m | Valuation ($) 136.5 m |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $37.4m (FY, 2021) | Revenue (est.) $1.4m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $10.5m (FY, 2021) | Cost of goods $1.4m (FY, 2025) |
Net income | Net income ($6.2m) (FY, 2014) | Net income ($251.1m) (FY, 2021) | Net income ($62.4m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 2.8m | Total funding raised $ 51.5m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Epizyme
HQ
Cambridge, US
Employees
203
Epizyme is a clinical stage biopharmaceutical company focusing on treatments for blood cancer and tumors.
View companyOutlook Therapeutics
HQ
Woodbridge Township, US
Employees
17↓ 26% decrease
Outlook Therapeutics (formerly Oncobiologics) is a clinical stage biopharmaceutical company focused on identifying, developing, manufacturing and commercializing complex biosimilar therapeutics.
View company